Product Reports Resources Pricing Login Book a demo

Vireo Growth

Biotech & Life Sciences · Minneapolis, United States · Founded 2014 · IPO 2019

Cannabis company offering safe access, quality products, and community support through cultivation, manufacturing, and retail MoreLess

Vireo Growth Inc., operating as a vertically integrated multi-state cannabis company, has a complex history marked by several name changes, including Vireo Health and Goodness Growth Holdings. The business was first established in 2014 as Minnesota Medical Solutions. Its founder, Dr. Kyle Kingsley, a former emergency medicine physician, was motivated to enter the cannabis industry after observing patients find relief with medical cannabis, which he viewed as a safer alternative to opioids. His medical background has instilled a physician-led, science-focused approach within the company.

The company's journey began by securing one of two inaugural medical cannabis licenses in Minnesota, ranking first among a dozen applicants. This was followed by another significant milestone in 2015: winning one of only five highly competitive medical cannabis licenses in New York. Over the years, the company expanded its footprint through both organic growth and strategic acquisitions, becoming licensed in multiple states including Maryland, Arizona, and New Mexico. To fuel its expansion, the company went public on the Canadian Securities Exchange (CSE) in March 2019 through a reverse takeover transaction. In 2021, the company rebranded from Vireo Health to Goodness Growth Holdings to reflect a broader focus. A planned acquisition by Verano Holdings for $413 million was announced in February 2022 but was later terminated in October 2022. The company subsequently reverted to the name Vireo Growth Inc. in June 2024.

Vireo Growth's business model is centered on the cultivation, manufacturing, and sale of cannabis. The company operates environmentally friendly greenhouses and state-of-the-art labs to produce a variety of pharmaceutical-grade cannabis products. Its revenue is generated through the sale of these products via its own retail dispensaries—operating under brands like Green Goods and Vireo Health—and through wholesale distribution to third-party dispensaries. The product portfolio is diverse, including dry flower, concentrates, vapes, topicals, tablets, and chews under brands such as Vireo Spectrum, 1937 Cannabis, Hi-Color, and others, catering to both medical patients and adult-use consumers. The company serves qualifying patients in medical markets and adult-use consumers in states where it is permitted. In a strategic move announced in late 2024, Vireo secured significant financing and announced mergers with four single-state operators in Missouri, Nevada, Utah, and Florida, aiming to expand its national platform under a decentralized model that empowers local market leadership.

Keywords: cannabis cultivation, medical cannabis, multi-state operator, cannabis products, Vireo Health, Goodness Growth, Kyle Kingsley, cannabis dispensaries, pharmaceutical-grade cannabis, cannabis extracts, vertically integrated cannabis, adult-use cannabis, cannabis wholesale, Green Goods, 1937 Cannabis, cannabis brand portfolio, cannabis market expansion, cannabis mergers and acquisitions, cannabis financing, cannabis industry

Valuation $1.04B
Revenue $778M
EBITDA $44M
Total funding $10–50M

Company overview

Vireo Growth company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2014
Headquarters
Minneapolis, United States
Employees
347
Open positions
4
Dealroom signal
90.3
Investment activity
12 companies · latest Aug 2026
Capital deployed
Preferred round
ACQUISITION
client focusb2bsub industryPharmaceuticalbusiness modelManufacturingindustryHealthsectorBiotechnologysectorCannabissectorBiotech and PharmasectorDT and LSsectorscience-based

Valuation & funding

Vireo Growth funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO DEBTDebt Aug 2026 $65M Bank of Montreal · BMO Capital Markets
POST IPO DEBTDebt Jul 2025 $153M Undisclosed
POST IPO EQUITYOther financing Dec 2024 $75M Undisclosed
PRIVATE PLACEMENT NON VCOther financing May 2024 $700K Undisclosed
POST IPO CONVERTIBLEOther financing May 2023 $2M Undisclosed
ACQUISITIONExit Feb 2022 Verano Holdings
POST IPO DEBTDebt Mar 2021 Chicago Atlantic
POST IPO EQUITYOther financing Mar 2020 Undisclosed
IPOExit Mar 2019 Undisclosed
POST IPO EQUITYOther financing Mar 2019 Undisclosed
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMarginProfitMargin
2026 $778M +189.3% $44M 5.6% −$68M -8.8%
2025 $269M +170.4% $44M 16.3% −$68M -25.3%
2024 $99M +12.8% $22M 22.5% −$28M -28.2%
2023 $88M +18.1% $22M 24.9%
2022 $75M +37.1% −$4.4M -5.9%
2021 $54M +10.6% −$19M -35.4%
2020 $49M −$22M -44.7%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Vireo Growth website traffic

Latest recorded traffic for Vireo Growth is 6.3K monthly website visits, down 8.7% over the last three months. Vireo Growth's team grew 35.5% over the past year.

Latest monthly visits6.3K 3-month web change-8.7% 1-year team growth+35.5%
Monthly website visits11 observations · Jun 2024–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Vireo Growth compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Capital deployed

Vireo Growth investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

Talent graph

Vireo Growth's talent

Book a demo to see the people
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Vireo Growth's cap table

Sourced from Dealroom's funding and investor records.

Series B+ 4 investors entered at this stage
Merida Capital Partners
Chicago Atlantic
Bank of Montreal
BMO Capital Markets
Other known 1 additional known investor
Verano Holdings

Global footprint

Where Vireo Growth has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States93.5%
🇻🇳 Vietnam6%
2 countries shown

In the news

Latest news about Vireo Growth

Recent press, funding announcements, and product moves mentioning Vireo Growth — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Vireo Growth

An AI-synthesized read of the highest-engagement posts about Vireo Growth on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vireo Growth’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.